Autism - Pipeline Review, H1 2019

SKU ID :GMD-13385831 | Published Date: 23-Apr-2019 | No. of pages: 195
Table of Contents Introduction Autism - Overview Autism - Therapeutics Development Autism - Therapeutics Assessment Autism - Companies Involved in Therapeutics Development Autism - Drug Profiles Autism - Dormant Projects Autism - Discontinued Products Autism - Product Development Milestones Appendix
List of Tables Number of Products under Development for Autism, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products under Development by Companies, H1 2019 (Contd..1), H1 2019 Number of Products under Development by Universities/Institutes, H1 2019 Products under Development by Companies, H1 2019 Products under Development by Companies, H1 2019 (Contd..1), H1 2019 Products under Development by Companies, H1 2019 (Contd..2), H1 2019 Products under Development by Universities/Institutes, H1 2019 Number of Products by Stage and Target, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 Number of Products by Stage and Mechanism of Action, H1 2019 (Contd..1), H1 2019 Number of Products by Stage and Route of Administration, H1 2019 Number of Products by Stage and Molecule Type, H1 2019 Autism - Pipeline by 4D Pharma PLC, H1 2019 Autism - Pipeline by AgeneBio Inc, H1 2019 Autism - Pipeline by AMO Pharma Ltd, H1 2019 Autism - Pipeline by APeT Holding BV, H1 2019 Autism - Pipeline by BioHealthonomics Inc, H1 2019 Autism - Pipeline by Blackthorn Therapeutics Inc, H1 2019 Autism - Pipeline by BrainStorm Cell Therapeutics Inc, H1 2019 Autism - Pipeline by Curemark LLC, H1 2019 Autism - Pipeline by Epigen Biosciences Inc, H1 2019 Autism - Pipeline by Evgen Pharma Plc, H1 2019 Autism - Pipeline by F. Hoffmann-La Roche Ltd, H1 2019 Autism - Pipeline by GlaxoSmithKline Plc, H1 2019 Autism - Pipeline by GW Pharmaceuticals Plc, H1 2019 Autism - Pipeline by Immuron Ltd, H1 2019 Autism - Pipeline by Insys Therapeutics Inc, H1 2019 Autism - Pipeline by Intra-Cellular Therapies Inc, H1 2019 Autism - Pipeline by Johnson & Johnson, H1 2019 Autism - Pipeline by Leading BioSciences Inc, H1 2019 Autism - Pipeline by Omeros Corp, H1 2019 Autism - Pipeline by OptiNose US Inc, H1 2019 Autism - Pipeline by Ovensa Inc, H1 2019 Autism - Pipeline by Panorama Research Inc, H1 2019 Autism - Pipeline by RespireRx Pharmaceuticals Inc, H1 2019 Autism - Pipeline by Reviva Pharmaceuticals Inc, H1 2019List of Figures Number of Products under Development for Autism, H1 2019 Number of Products under Development by Companies, H1 2019 Number of Products by Top 10 Targets, H1 2019 Number of Products by Stage and Top 10 Targets, H1 2019 Number of Products by Top 10 Mechanism of Actions, H1 2019 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019 Number of Products by Top 10 Routes of Administration, H1 2019 Number of Products by Stage and Top 10 Routes of Administration, H1 2019 Number of Products by Molecule Types, H1 2019 Number of Products by Stage and Molecule Types, H1 2019
4D Pharma PLC AgeneBio Inc AMO Pharma Ltd APeT Holding BV BioHealthonomics Inc Blackthorn Therapeutics Inc BrainStorm Cell Therapeutics Inc Curemark LLC Epigen Biosciences Inc Evgen Pharma Plc F. Hoffmann-La Roche Ltd GlaxoSmithKline Plc GW Pharmaceuticals Plc Immuron Ltd Insys Therapeutics Inc Intra-Cellular Therapies Inc Johnson & Johnson Leading BioSciences Inc Omeros Corp OptiNose US Inc Ovensa Inc Panorama Research Inc RespireRx Pharmaceuticals Inc Reviva Pharmaceuticals Inc Sosei Heptares Sumitomo Dainippon Pharma Co Ltd Zynerba Pharmaceuticals Inc
  • PRICE
  • $2000
    $6000

Our Clients